AIM IMMUNOTECH INC. Current Assets
AIM IMMUNOTECH INC. (AIM) had Current Assets of $10.43 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $10.43M.
- 2026-03-31: Assets, Current $6.21M.
- 2025-12-31: Assets, Current $3.29M.
- 2025-09-30: Assets, Current $2.58M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $10.43M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $6.21M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $3.29M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-17 |
| 2025-06-30 | $1.02M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.58M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.18M 10-K · filed 2026-03-27 |
| 2024-09-30 | $7.57M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $10.36M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.31M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $14.56M 10-K · filed 2025-03-27 |
| 2023-09-30 | $22.74M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $28.87M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $33.16M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $36.32M 10-K · filed 2024-04-01 |
| 2022-09-30 | $41.15M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $46.05M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $50.38M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $50.21M 10-K · filed 2023-03-31 |
| 2021-09-30 | $38.04M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $41.33M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $51.22M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $40.31M 10-K · filed 2022-03-31 |
| 2020-09-30 | $39.76M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $35.16M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $29.71M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $10.45M 10-K · filed 2021-03-31 |
| 2019-09-30 | $12.62M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.75M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $5.86M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.80M 10-K · filed 2020-03-30 |
| 2018-09-30 | $4.94M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $5.29M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $5.66M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $3.50M 10-K · filed 2019-04-01 |
| 2017-09-30 | $3.73M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.68M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $5.19M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $6.94M 10-K · filed 2018-03-30 |
| 2016-09-30 | $9.33M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $10.73M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $9.54M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $10.57M 10-K · filed 2017-03-31 |
| 2015-09-30 | $13.98M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $17.06M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $17.92M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $16.51M 10-K · filed 2016-03-29 |
| 2014-09-30 | $17.67M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $20.46M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $21.89M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $18.55M 10-K · filed 2015-03-19 |
| 2013-09-30 | $29.55M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $32.88M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $38.58M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $44.73M 10-K · filed 2014-03-14 |
| 2012-09-30 | $36.45M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $30.49M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $33.64M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $31.79M 10-K · filed 2013-03-18 |
| 2011-09-30 | $34.22M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $33.04M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $36.67M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |